by Michael G Head, Sian Goss, Yann Gelister
Lancet Glob Health 2017, Published Online June 28, 2017
Total domestic and international funding for malaria is inadequate to achieve WHO global targets in burden reduction by 2030. Some countries receive reasonably large investments in malaria-related research (Tanzania, Kenya, Uganda), whereas others receive little or no investments (Sierra Leone, Central African Republic). Research investments are typically highest in countries where funding for malaria control is also high. Investment strategies should consider more equitable research and operational investments across countries to include currently neglected and susceptible populations.